Skip to main content

ScienceDex / Researcher record

Chou, James Jeiwen

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #7,503
  • Sustained Excellence
  • R01 Holder
  • Long-Funded
  • Translational

NIH Funding · FY2022

$1.2M
Full award amounts, FY2022
2
Records listing this PI
#7,503
By linked amount among FY2022 PIs
2008
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2008$947,9793#6,658
2009$1,118,2084#6,987
2010$5,181,3135#837
2011$2,297,2431#2,339
2012$2,296,5941#2,300
2013$2,216,1131#2,265
2014$2,574,8892#1,905
2016$465,1861#17,072
2017$1,307,6462#4,905
2018$1,268,4662#5,501
2019$1,258,2892#6,077
2020$1,609,3382#1,294
2021$1,238,0152#7,060
2022$1,229,9972#7,503

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20083 records
  2. FY20094 records
  3. FY20105 records
  4. FY20111 record
  5. FY20121 record
  6. FY20131 record
  7. FY20142 records
  8. FY20161 record
  9. FY20172 records
  10. FY20182 records
  11. FY20192 records
  12. FY20202 records
  13. FY20212 records
  14. FY2022 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Chou, James Jeiwen. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2008 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award categories

  • Biochemistry
  • Internal Medicine

FY2022 award records by amount

NIH award records listing Chou, James Jeiwen as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI150709-03R01Contact PI
    CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
    Harvard Medical School · Biochemistry (NIH department code)
    $788K
    award amount
  • 5R35GM140887-02R35Contact PI
    Structural and Functional Roles of the Membrane-Related Components of Single-Pass Membrane Proteins
    Harvard Medical School · Internal Medicine (NIH department code)
    $442K
    award amount

Award organization

Organizations that administered FY2022 awards listing Chou, James Jeiwen as a PI.

FY2022 award administered by Harvard Medical School (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2008
    First NIH Award
    Harvard Medical School
  2. 2008
    $500K Cumulative Funding
  3. 2008
    Entered Top 50% Nationally
    Ranked #6658
  4. 2009
    $1M Cumulative Funding
  5. 2009
    $2M Cumulative Funding
  6. 2010
    $5M Cumulative Funding
  7. 2010
    Entered Top 25% Nationally
    Ranked #837
  8. 2010
    Entered Top 10% Nationally
    Ranked #837
  9. 2010
    Entered Top 5% Nationally
    Ranked #837
  10. 2012
    $10M Cumulative Funding
  11. 2012
    R01 Grant Holder
  12. 2022
    $25M Cumulative Funding